+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

MiNK Therapeutics

INKTNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.860300

-0.02-2.24%

Pre-Market: Jul 19, 7:40 PM EDT

15 minutes delayed

MiNK Therapeutics (INKT) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for MiNK Therapeutics (NASDAQ:INKT) Stock

MiNK Therapeutics Stock (NASDAQ: INKT)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, May 22, 2024

MiNK Presents AgenT-797 Clinical Activity in ...
Benzinga Newsdesk

Tuesday, May 14, 2024

MiNK Therapeutics shares are trading lower. T...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
MiNK Therapeutics Q1 2024 GAAP EPS $(0.11) Be...
Benzinga Newsdesk

Monday, May 13, 2024

Why MiNK Therapeutics Stock Is Up 11% Monday
Dylan Berman
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
MiNK Therapeutics shares are trading higher a...
Benzinga Newsdesk
MiNK Therapeutics To Sell Securities In Priva...
Benzinga Newsdesk

Monday, April 08, 2024

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
MiNK Therapeutics Announces Preclinical Activ...
Benzinga Newsdesk

Friday, April 05, 2024

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Thursday, March 21, 2024

HC Wainwright & Co. Maintains Buy on MiNK The...
Benzinga Newsdesk
MiNK Therapeutics Q4 EPS $(0.16) Misses $(0.1...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights

Wednesday, March 20, 2024

Earnings Outlook For MiNK Therapeutics
Benzinga Insights

Wednesday, March 06, 2024

MiNK Announces Preclinical Data Showcasing Ac...
Benzinga Newsdesk

Wednesday, February 14, 2024

MiNK Therapeutics, Inc. Announces First Refra...
Benzinga Newsdesk

Wednesday, February 07, 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Tuesday, February 06, 2024

MiNK Therapeutics' AgenT-797 Presents Results...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Tuesday, January 30, 2024

MiNK Therapeutics' MiNK's AgenT-797 Offers Ne...
Benzinga Newsdesk

Wednesday, December 20, 2023

MiNK Therapeutics And ImmunoScape Collaborate...
Benzinga Newsdesk

Thursday, November 09, 2023

MiNK Therapeutics Q3 2023 EPS $(0.15) Beats $...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights

Friday, November 03, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
MiNK Therapeutics Presents Clinical Activity ...
Benzinga Newsdesk

Tuesday, October 17, 2023

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying
Lisa Levin

Monday, October 09, 2023

Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
Lisa Levin

Wednesday, October 04, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Tuesday, August 29, 2023

MiNK Therapeutics 10% Owner Makes $281K Stock Purchase
Benzinga Insights

Thursday, August 10, 2023

HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk
MiNK Therapeutics Q2 EPS $(0.18) Beats $(0.20...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights

Thursday, June 22, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights

Monday, May 22, 2023

MiNK Presents Clinical Data On Allogeneic iNK...
Benzinga Newsdesk

Monday, May 15, 2023

Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin

Friday, May 12, 2023

The Latest Analyst Ratings for MiNK Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on MiNK The...
Benzinga Newsdesk

Thursday, May 11, 2023

Earnings Scheduled For May 11, 2023
Benzinga Insights
Recap: MiNK Therapeutics Q1 Earnings
Benzinga Insights
MiNK Therapeutics Q1 EPS $(0.17) Beats $(0.24...
Benzinga Newsdesk

Friday, May 05, 2023

First Foundation And 2 Other Penny Stocks Insiders Are Aggressively Buying
Lisa Levin

Thursday, May 04, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights

Wednesday, April 19, 2023

HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk

Tuesday, April 18, 2023

MiNK Therapeutics Announces Clinical Data Of Allogeneic iNKT Cells In Solid Tumor Cancers At The AACR Annual Meeting
Happy Mohamed

Thursday, March 30, 2023

Agenus Announces Dividend Of 5M Shares Of Its Subsidiary, MiNK Therapeutics, To Shareholders Of Agenus As Of April 17, 2023
Happy Mohamed

Wednesday, March 22, 2023

Evercore ISI Group Maintains Outperform on Mi...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MiNK Th...
Benzinga Newsdesk

Tuesday, March 21, 2023

MiNK Therapeutics Q4 EPS $(0.23) Misses $(0.2...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved